- US-listed companies
- MEDICINOVA INC
- Income statement
MEDICINOVA INCMNOV
Market cap
$72.1M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Revenue | 2 | 2 | 3,257 | - | - | - | - | - | - | - | 4 | - | 1,000,000 | - |
| Revenue growth (%) | - | - | - | - | - | - | - | - | - | - | - | - | ||
| Cost of revenue | 1 | 1 | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & development | 162 | 167 | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating margin (%) | - | - | - | - | - | - | - | - | - | |||||
| Operating income | -16,108,434 | -10,945,356 | -4,020,540 | -9,223,011 | -8,822,386 | -10,881,834 | -13,027,093 | -15,586,826 | -14,031,077 | -14,178,323 | -10,215,812 | -14,628,649 | -9,900,265 | -12,675,331 |
| Operating expenses | 269 | 281 | 10 | 9 | 9 | 11 | 13 | 16 | 14 | 14 | 14 | 15 | 11 | 13 |
| Income before tax | -17,722,503 | -10,950,170 | -4,024,493 | -9,199,264 | -8,837,720 | -10,862,225 | -12,907,186 | -14,669,811 | -12,928,998 | -13,855,545 | -10,131,684 | -14,066,261 | -8,568,469 | -11,044,012 |
| Pretax margin (%) | -1,137.4 | -463.8 | -123,564.4 | - | - | - | - | - | - | - | -250.9 | - | -856.8 | - |
| Provision for income taxes | 64,817 | 75,961 | 4,035 | -3,972 | 7,359 | 3,754 | -1,744,050 | 5,276 | 12,660 | -1,648 | 2,568 | 2,822 | 3,047 | 5,537 |
| Effective tax rate (%) | ||||||||||||||
| Net income | -17,734,076 | -10,961,314 | -4,028,528 | -9,195,292 | -8,845,079 | -10,865,979 | -11,163,136 | -14,675,087 | -12,941,658 | -13,853,897 | -10,134,252 | -14,069,083 | -8,571,516 | -11,049,549 |
| Net income margin (%) | - | - | - | - | - | - | - | - | - | |||||
| Earnings per share | - | - | - | - | - | - | - | - | - | - | - | -0.29 | -0.17 | -0.23 |
| Diluted EPS | - | - | - | - | - | - | - | - | - | - | - | -0.29 | -0.17 | -0.23 |
| EBITDA | ||||||||||||||
| EBITDA margin (%) | - | - | - | - | - | - | - | - | - |